Skip to main content
. Author manuscript; available in PMC: 2024 Dec 17.
Published in final edited form as: Gastrointest Endosc. 2023 Dec 11;99(6):962–970. doi: 10.1016/j.gie.2023.12.008

Figure 2.

Figure 2.

Long-term follow-up of the randomized prospective ChARM and ChARM II trials showing the durability of endoscopic ultrasound (EUS)–guided chemoablation. Shown are the volume calculations from baseline to long-term follow-up after EUS-guided chemoablation treatment using a mixture of gemcitabine + paclitaxel.